Explore the complete record of transactions filed by TAKEDA PHARMACEUTICAL CO LTD, External Director. Insider active across 4 companies, notably Phathom Pharmaceuticals, Inc.. Aggregated, 51 disclosures have been recorded. Total volume traded: €10.8m. The latest transaction was filed on 14 March 2022 — X. Regulator: SEC (Form 4). The full history is accessible without signup.
25 of 51 declarations
Takeda Pharmaceutical Co., Ltd. is a global pharmaceutical company with a governance model centered on a board that combines internal and independent external directors. Public sources describe Takeda as a major international life sciences company with a significant U.S. presence and a board structure focused on strategic oversight, transparency, and long-term value creation. In this context, the most notable and recent role associated with Takeda is that of External Director, rather than an operating executive management position. ([takeda.com](https://www.takeda.com/about/board-of-directors/?utm_source=openai)) From a career-path perspective, Takeda emphasizes a board composed of experienced leaders from pharmaceuticals, biotechnology, finance, and corporate governance. External directors contribute to oversight of major strategic decisions, medium- to long-term plans, portfolio direction, and broader management priorities. Takeda also states that its board addresses important matters such as corporate philosophy and management policy, with a majority of independent external directors. ([takeda.com](https://www.takeda.com/about/corporate-governance/governance-structure/?utm_source=openai)) As for the affiliations listed — Phathom Pharmaceuticals, Day One Biopharmaceuticals, Theseus Pharmaceuticals, and Xilio Therapeutics — the sources reviewed do not clearly establish that Takeda Pharmaceutical Co., Ltd. personally serves in an executive or board capacity at each of these companies. To avoid inventing details, it is best to stay generic: these are peer companies in the U.S. biopharma ecosystem, but the verified information does not support assigning Takeda a specific role in each one. ([phathompharma.com](https://www.phathompharma.com/about-us/?utm_source=openai)) For a corporate-governance SEO profile, Takeda can therefore be framed as a highly experienced figure in international pharmaceutical oversight, with expertise tied to supervising large healthcare organizations, capital allocation, portfolio strategy, and regulated-industry governance. Takeda’s board model is notable for its independence, its supervisory scope, and its emphasis on accountability and long-term stewardship. ([takeda.com](https://www.takeda.com/about/corporate-governance/governance-structure/?utm_source=openai))